Women's Medical Research Group

Hormone Replacement Therapy (Vaginal Atrophy) : 

Study: A randomized, double-blind, vehicle-controlled study of the safety and efficacy of study drug in the treatment of symptoms of VALVOVAGINAL ATROPHY in postmenopausal women.

Description: Postmenopausal women with Vulvovaginal Atrophy may experience: Vaginal Dryness, Burning,Burning during urination,discomfort during intercourse

Entry Criteria:

  • Females > 40 or with Bilateral Oophorectomy > 35
  • 12 months Amenorrhea (no menses )
  • No known hypersensitivity to estrogen or progestin therapy
  • No insulin dependent Diabetes
  • previous hormone uses: Transdermal 4 weeks, Oral 8 weeks, Intrauterine 8 weeks . wash out period is allowed

Study Duration: 3 months

Compensation: The Subject will receive all study related office visits, laboratory testing, and medication at no charge. Additionally the subject may be compensated for time and travel expenses.

Contact Vicki Amole: (727) 724-9730 vickia@xxresearch.com

InvestigatorsG
InvestigatorsG

Home | About | Products | News | Contact